INULIN PRODUCTS WITH IMPROVED NUTRITIONAL PROPERTIES
    1.
    发明申请
    INULIN PRODUCTS WITH IMPROVED NUTRITIONAL PROPERTIES 审中-公开
    INULIN产品具有改进的营养特性

    公开(公告)号:US20070042992A1

    公开(公告)日:2007-02-22

    申请号:US11551592

    申请日:2006-10-20

    CPC classification number: A61K31/733 A23L29/244 C08B37/18

    Abstract: The invention relates to novel inulin products and compositions thereof, to their manufacture, to their use for modifying and modulating the bacterial flora and the fermentation pattern of inulin in the large intestine of humans, mammals or other vertebrates, to their use for providing improved inulin-associated nutritional effects/benefits, as well as to their use for the manufacture of consumer products and compositions for providing said effects/benefits in healthy, disfunctioned and diseased humans, mammals and other vertebrates. The novel inulin products consist of a particular mixture of an easily fermentable inulin (EFI) component and a hardly fermentable inulin (HFI) component. The nutritional effects/benefits include dietary fibre effects, improved mineral absorption, particularly calcium and magnesium, bone mineral density increase, reduction of bone mineral density loss, modulation of lipid metabolism, stimulation of the immune system, and anti-cancer effects. The novel inulin products are particularly suitable for the manufacture of a composition or a medicament for preventing, for postponing and/or for treating osteoporosis in humans, particularly in post-menopausal women and elderly people.

    Abstract translation: 本发明涉及新颖的菊粉产品及其组合物,用于其制造,用于修饰和调节人类,哺乳动物或其他脊椎动物大肠中菊糖的细菌菌群和发酵模式,用于提供改良的菊粉 相关的营养效果/益处,以及它们用于制造消费品和组合物的用途,用于在健康,失能和患病的人,哺乳动物和其他脊椎动物中提供所述效果/益处。 新颖的菊粉产品由容易发酵的菊粉(EFI)组分和几乎不可发酵的菊粉(HFI)组分的特定混合物组成。 营养效应/益处包括膳食纤维作用,改善矿物质吸收,特别是钙和镁,骨矿物质密度增加,骨矿物质密度损失减少,脂质代谢调节,免疫系统刺激和抗癌作用。 新颖的菊粉产品特别适用于制造用于预防,推迟和/或治疗人类,特别是在绝经后妇女和老年人中的骨质疏松症的组合物或药物。

    Hydrated lipophilic composition and process for producing it
    3.
    发明授权
    Hydrated lipophilic composition and process for producing it 失效
    水合亲脂性组合物及其生产方法

    公开(公告)号:US6010735A

    公开(公告)日:2000-01-04

    申请号:US128945

    申请日:1998-08-05

    CPC classification number: A23G1/46 A23G1/325 A23G1/40 A23G1/48

    Abstract: The present invention is related to a lipophilic composition which is made of: a) as the principal lipophilic ingredient, a chocolate mass or a chocolate substitute mass which does not contain water continuous phase, and b) an aqueous ingredient containing between 25 and 90% water, wherein the water is immobilized in a gel obtained from an element selected from the group consisting of an edible carbohydrate with gelling properties, a pectin with gelling properties or a mixture thereof, and wherein the aqueous ingredient is substantially uniformly and homogeneously dispersed in the principal lipophilic ingredient and wherein the lipophilic composition has a softening temperature higher than 28.degree. C.

    Abstract translation: 本发明涉及一种亲脂性组合物,其由以下制成:a)作为主要亲脂性成分,不含水连续相的巧克力块或巧克力代用品,以及b)含有25-90% 水,其中将水固定在由选自具有胶凝性的可食用碳水化合物,具有胶凝特性的果胶或其混合物组成的组中获得的凝胶中,并且其中所述水性成分基本上均匀均匀地分散在 主亲脂性成分,其中亲脂性组合物的软化温度高于28℃。

    INULIN PRODUCTS WITH IMPROVED NUTRITIONAL PROPERTIES
    4.
    发明申请
    INULIN PRODUCTS WITH IMPROVED NUTRITIONAL PROPERTIES 审中-公开
    INULIN产品具有改进的营养特性

    公开(公告)号:US20100261671A1

    公开(公告)日:2010-10-14

    申请号:US12822749

    申请日:2010-06-24

    CPC classification number: A61K31/733 A23L29/244 C08B37/18

    Abstract: The invention relates to novel inulin products and compositions thereof, to their manufacture, to their use for modifying and modulating the bacterial flora and the fermentation pattern of inulin in the large intestine of humans, mammals or other vertebrates, to their use for providing improved inulin-associated nutritional effects/benefits, as well as to their use for the manufacture of consumer products and compositions for providing said effects/benefits in healthy, disfunctioned and diseased humans, mammals and other vertebrates.The novel inulin products consist of a particular mixture of an easily fermentable inulin (EFI) component and a hardly fermentable inulin (HFI) component.The nutritional effects/benefits include dietary fibre effects, improved mineral absorption, particularly calcium and magnesium, bone mineral density increase, reduction of bone mineral density loss, modulation of lipid metabolism, stimulation of the immune system, and anti-cancer effects. The novel inulin products are particularly suitable for the manufacture of a composition or a medicament for preventing, for postponing and/or for treating osteoporosis in humans, particularly in post-menopausal women and elderly people.

    Abstract translation: 本发明涉及新颖的菊粉产品及其组合物,用于其制造,用于修饰和调节人类,哺乳动物或其他脊椎动物大肠中菊糖的细菌菌群和发酵模式,用于提供改良的菊粉 相关的营养效果/益处,以及它们用于制造消费品和组合物的用途,用于在健康,失能和患病的人,哺乳动物和其他脊椎动物中提供所述效果/益处。 新颖的菊粉产品由容易发酵的菊粉(EFI)组分和几乎不可发酵的菊粉(HFI)组分的特定混合物组成。 营养效应/益处包括膳食纤维作用,改善矿物质吸收,特别是钙和镁,骨矿物质密度增加,骨矿物质密度损失减少,脂质代谢调节,免疫系统刺激和抗癌作用。 新颖的菊粉产品特别适用于制造用于预防,推迟和/或治疗人类,特别是在绝经后妇女和老年人中的骨质疏松症的组合物或药物。

    Inhibition of systemic infections in humans and vertebrates by dietary fibers
    5.
    发明授权
    Inhibition of systemic infections in humans and vertebrates by dietary fibers 有权
    通过膳食纤维抑制人和脊椎动物的全身感染

    公开(公告)号:US07431939B1

    公开(公告)日:2008-10-07

    申请号:US09671106

    申请日:2000-09-28

    Abstract: The use of a dietary fiber or a mixture of dietary fibers for the manufacture of a composition, being a pharmaceutical composition or a functional food or a functional feed, for the prevention, the inhibition and/or the treatment of systemic infections in humans and in vertebrates caused by pathogenic bacteria is disclosed.A method for the prevention, the inhibition and/or the treatment of systemic infections in humans and in vertebrates caused by pathogenic bacteria, comprising administration to said beings, orally, through tube feeding or rectally, a composition containing an effective amount of a dietary fiber or mixture of dietary fibers is also disclosed.The dietary fiber is preferably a fructan, typically inulin and/or oligofructose, most preferably chicory inulin with an average degree of polymerization (DP) of at least 20.

    Abstract translation: 使用膳食纤维或膳食纤维的混合物来制造组合物,作为药物组合物或功能性食品或功能性饲料,用于预防,抑制和/或治疗人体系统感染和 公开了由致病菌引起的脊椎动物。 一种用于预防,抑制和/或治疗由致病菌引起的人类和脊椎动物的全身感染的方法,其包括通过口服,通过管饲或直肠给予所述生物,含有有效量的膳食纤维的组合物 或膳食纤维的混合物也被公开。 膳食纤维优选为果聚糖,通常为菊粉和/或低聚果糖,最优选为具有至少20的平均聚合度(O)的“菊苣菊糖”(DP)。

    Inulin products with improved nutritional properties
    6.
    发明授权
    Inulin products with improved nutritional properties 有权
    具有改善营养特性的菊粉制品

    公开(公告)号:US07812004B2

    公开(公告)日:2010-10-12

    申请号:US10182064

    申请日:2001-02-14

    CPC classification number: A61K31/733 A23L29/244

    Abstract: The invention relates to novel inulin products and compositions thereof, to their manufacture, to their use for modifying and modulating the bacterial flora and the fermentation pattern of inulin in the large intestine of humans, mammals or other vertebrates, to their use for providing improved inulin-associated nutritional effects/benefits, as well as to their use for the manufacture of consumer products and compositions for providing said effects/benefits in healthy, disfunctioned and diseased humans, mammals and other vertebrates.The novel inulin products consist of a particular mixture of an easily fermentable inulin (EFI) component and a hardly fermentable inulin (HFI) component.The nutritional effects/benefits include dietary fiber effects, improved mineral absorption, particularly calcium and magnesium, bone mineral density increase, reduction of bone mineral density loss, modulation of lipid metabolism, stimulation of the immune system, and anti-cancer effects. The novel inulin products are particularly suitable for the manufacture of a composition or a medicament for preventing, for postponing and/or for treating osteoporosis in humans, particularly in post-menopausal women and elderly people.

    Abstract translation: 本发明涉及新颖的菊粉产品及其组合物,用于其制造,用于修饰和调节人类,哺乳动物或其他脊椎动物大肠中菊糖的细菌菌群和发酵模式,用于提供改良的菊粉 相关的营养效果/益处,以及它们用于制造消费品和组合物的用途,用于在健康,失能和患病的人,哺乳动物和其他脊椎动物中提供所述效果/益处。 新颖的菊粉产品由容易发酵的菊粉(EFI)组分和几乎不可发酵的菊粉(HFI)组分的特定混合物组成。 营养效应/益处包括膳食纤维作用,改善矿物质吸收,特别是钙和镁,骨矿物质密度增加,骨矿物质密度损失减少,脂质代谢调节,免疫系统刺激和抗癌作用。 新颖的菊粉产品特别适用于制造用于预防,推迟和/或治疗人类,特别是在绝经后妇女和老年人中的骨质疏松症的组合物或药物。

    Stabilized food composition
    7.
    发明授权
    Stabilized food composition 失效
    稳定的食物成分

    公开(公告)号:US06521276B1

    公开(公告)日:2003-02-18

    申请号:US08578616

    申请日:1996-01-11

    Applicant: Anne Frippiat

    Inventor: Anne Frippiat

    CPC classification number: A23C19/054 A23D7/015 A23L13/65 A23L27/60 A23L29/244

    Abstract: A stabilized food composition with a reduced dry matter content, wherein the stabilizing agent is a fructane or fructane mixture in an amount of 1-15 wt % and to 1-25% of the water content of said food composition.

    Abstract translation: 一种具有减少的干物质含量的稳定的食物组合物,其中所述稳定剂是所述食物组合物的含水量为1-15重量%和1-25重量%的果聚糖或果聚糖混合物。

    Fructan containing composition for the prevention and treatment of colon cancer and method for the prevention and treatment of same
    8.
    发明授权
    Fructan containing composition for the prevention and treatment of colon cancer and method for the prevention and treatment of same 失效
    用于预防和治疗结肠癌的含有果聚糖的组合物及其预防和治疗方法

    公开(公告)号:US06500805B2

    公开(公告)日:2002-12-31

    申请号:US09424168

    申请日:1999-11-19

    CPC classification number: A61K31/733 A23L29/055 A23L29/244

    Abstract: The use is provided of a fructran with an average degree of polymerisation of at least 15 for the manufacture of a composition for the prevention and/or treatment of colon cancer in non-bovine mammals, particularly in human beings. Also provided is a method of prevention and treatment of colon cancer in a non-bovine mammal, particularly in a human being, comprising administering to said mammal a composition comprising an effective dose of a fructan with an average degree of polymerisation of at least 15. The said composition can be a medicament as well as a functional food. In a preferrred embodiment the fructan is inulin, more preferably inulin with an average degree of polymerisation of at least 20.

    Abstract translation: 使用平均聚合度为至少15的果聚糖,用于制造用于预防和/或治疗非牛哺乳动物,特别是人类中的结肠癌的组合物。还提供了一种方法 预防和治疗非牛哺乳动物,特别是人的结肠癌,包括向所述哺乳动物施用包含平均聚合度至少为15的有效剂量的果聚糖的组合物。所述组合物可以是 药物以及功能性食品。 在优选的实施方案中,果聚糖是菊粉,更优选菊糖,其平均聚合度至少为20。

Patent Agency Ranking